Jazz Pharmaceuticals plc Increase (Decrease) in Other Noncurrent Liabilities
Jazz Pharmaceuticals plc (JAZZ) reported Increase (Decrease) in Other Noncurrent Liabilities of $5.29 million for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2025-11-05
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent liabilities for the quarter ending 2025-09-30 was $529.00K, a 75.52% decline year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent liabilities for the quarter ending 2025-06-30 was $792.00K, a 60.20% decline year-over-year.
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent liabilities for the quarter ending 2025-03-31 was $3.97M.
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent liabilities for the quarter ending 2024-12-31 was -$14.85M.
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent liabilities for fiscal 2024 was -$14.53M.
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent liabilities for fiscal 2023 was -$6.17M.
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent liabilities for fiscal 2022 was -$11.40M.
- Jazz Pharmaceuticals plc increase (decrease) in other noncurrent liabilities for fiscal 2021 was -$4.95M.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2025-09-30 | $529.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $1.32M derived: sum of 2 quarters · filed 2025-11-05 | $5.29M 10-Q · filed 2025-11-05 | -$9.56M derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | $792.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $4.76M 10-Q · filed 2025-08-06 | -$10.09M derived: sum of 3 quarters · filed 2025-08-06 | -$7.93M derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-03-31 | $3.97M 10-Q · filed 2025-05-07 | -$10.88M derived: sum of 2 quarters · filed 2025-05-07 | -$8.72M derived: sum of 3 quarters · filed 2025-11-05 | -$6.73M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-12-31 | -$14.85M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$12.69M derived: sum of 2 quarters · filed 2025-11-05 | -$10.70M derived: sum of 3 quarters · filed 2025-11-05 | -$14.53M 10-K · filed 2025-02-26 |
| 2024-09-30 | $2.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $4.15M derived: sum of 2 quarters · filed 2025-11-05 | $320.00K 10-Q · filed 2025-11-05 | -$26.35M derived: sum of 4 quarters · filed 2025-11-05 |
| 2024-06-30 | $1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$1.84M 10-Q · filed 2025-08-06 | -$28.51M derived: sum of 3 quarters · filed 2025-08-06 | -$27.31M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$3.83M 10-Q · filed 2025-05-07 | -$30.50M derived: sum of 2 quarters · filed 2025-05-07 | -$29.30M derived: sum of 3 quarters · filed 2025-05-07 | -$11.84M derived: sum of 4 quarters · filed 2025-05-07 |
| 2023-12-31 | -$26.67M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$25.47M derived: sum of 2 quarters · filed 2025-02-26 | -$8.01M derived: sum of 3 quarters · filed 2025-02-26 | -$6.17M 10-K · filed 2025-02-26 |
| 2023-09-30 | $1.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $18.66M derived: sum of 2 quarters · filed 2024-11-07 | $20.50M 10-Q · filed 2024-11-07 | $2.34M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $17.46M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | $19.30M 10-Q · filed 2024-08-01 | $1.14M derived: sum of 3 quarters · filed 2025-02-26 | -$3.16M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $1.83M 10-Q · filed 2024-05-02 | -$16.33M derived: sum of 2 quarters · filed 2025-02-26 | -$20.62M derived: sum of 3 quarters · filed 2025-02-26 | -$14.69M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | -$18.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | -$22.46M derived: sum of 2 quarters · filed 2025-02-26 | -$16.53M derived: sum of 3 quarters · filed 2025-02-26 | -$11.40M 10-K · filed 2025-02-26 |
| 2022-09-30 | -$4.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $1.64M derived: sum of 2 quarters · filed 2023-11-08 | $6.77M 10-Q · filed 2023-11-08 | -$14.66M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $5.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $11.06M 10-Q · filed 2023-08-09 | -$10.36M derived: sum of 3 quarters · filed 2024-02-28 | -$5.23M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $5.13M 10-Q · filed 2023-05-10 | -$16.30M derived: sum of 2 quarters · filed 2024-02-28 | -$11.16M derived: sum of 3 quarters · filed 2024-02-28 | -$4.59M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | -$21.43M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$16.29M derived: sum of 2 quarters · filed 2024-02-28 | -$9.72M derived: sum of 3 quarters · filed 2024-02-28 | -$4.95M 10-K · filed 2024-02-28 |
| 2021-09-30 | $5.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $11.71M derived: sum of 2 quarters · filed 2022-11-09 | $16.48M 10-Q · filed 2022-11-09 | -$25.74M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | $6.57M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | $11.34M 10-Q · filed 2022-08-03 | -$30.88M derived: sum of 3 quarters · filed 2023-03-01 | -$23.54M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | $4.77M 10-Q · filed 2022-05-04 | -$37.45M derived: sum of 2 quarters · filed 2023-03-01 | -$30.11M derived: sum of 3 quarters · filed 2023-03-01 | -$11.51M derived: sum of 4 quarters · filed 2023-03-01 |
| 2020-12-31 | -$42.22M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$34.88M derived: sum of 2 quarters · filed 2023-03-01 | -$16.28M derived: sum of 3 quarters · filed 2023-03-01 | -$8.97M 10-K · filed 2023-03-01 |
| 2020-09-30 | $7.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $25.94M derived: sum of 2 quarters · filed 2021-11-09 | $33.25M 10-Q · filed 2021-11-09 | $40.45M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $18.60M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $25.91M 10-Q · filed 2021-08-03 | $33.11M derived: sum of 3 quarters · filed 2022-03-01 | $15.30M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $7.32M 10-Q · filed 2021-05-04 | $14.51M derived: sum of 2 quarters · filed 2022-03-01 | -$3.30M derived: sum of 3 quarters · filed 2022-03-01 | $4.10M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $7.20M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$10.62M derived: sum of 2 quarters · filed 2022-03-01 | -$3.21M derived: sum of 3 quarters · filed 2022-03-01 | $3.56M 10-K · filed 2022-03-01 |
| 2019-09-30 | -$17.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | -$10.41M derived: sum of 2 quarters · filed 2020-11-02 | -$3.63M 10-Q · filed 2020-11-02 | $3.66M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-06-30 | $7.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $14.18M 10-Q · filed 2020-08-04 | $21.47M derived: sum of 3 quarters · filed 2021-02-23 | $14.76M derived: sum of 4 quarters · filed 2021-02-23 |
| 2019-03-31 | $6.77M 10-Q · filed 2020-05-05 | $14.07M derived: sum of 2 quarters · filed 2021-02-23 | $7.36M derived: sum of 3 quarters · filed 2021-02-23 | $13.66M derived: sum of 4 quarters · filed 2021-02-23 |
| 2018-12-31 | $7.29M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-23 | $582.00K derived: sum of 2 quarters · filed 2021-02-23 | $6.89M derived: sum of 3 quarters · filed 2021-02-23 | $14.54M 10-K · filed 2021-02-23 |
| 2018-09-30 | -$6.71M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$407.00K derived: sum of 2 quarters · filed 2019-11-05 | $7.24M 10-Q · filed 2019-11-05 | $13.25M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $6.30M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $13.96M 10-Q · filed 2019-08-06 | $19.96M derived: sum of 3 quarters · filed 2020-02-25 | $17.36M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $7.65M 10-Q · filed 2019-05-07 | $13.65M derived: sum of 2 quarters · filed 2020-02-25 | $11.05M derived: sum of 3 quarters · filed 2020-02-25 | $18.41M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $6.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $3.40M derived: sum of 2 quarters · filed 2020-02-25 | $10.76M derived: sum of 3 quarters · filed 2020-02-25 | $18.93M 10-K · filed 2020-02-25 |
| 2017-09-30 | -$2.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $4.76M derived: sum of 2 quarters · filed 2018-11-06 | $12.93M 10-Q · filed 2018-11-06 | $17.78M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-06-30 | $7.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | $15.53M 10-Q · filed 2018-08-07 | $20.38M derived: sum of 3 quarters · filed 2019-02-26 | $24.14M derived: sum of 4 quarters · filed 2019-02-26 |
| 2017-03-31 | $8.17M 10-Q · filed 2018-05-08 | $13.02M derived: sum of 2 quarters · filed 2019-02-26 | $16.79M derived: sum of 3 quarters · filed 2019-02-26 | $23.98M derived: sum of 4 quarters · filed 2019-02-26 |
| 2016-12-31 | $4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $8.61M derived: sum of 2 quarters · filed 2019-02-26 | $15.81M derived: sum of 3 quarters · filed 2019-02-26 | $23.20M 10-K · filed 2019-02-26 |
| 2016-09-30 | $3.77M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $10.96M derived: sum of 2 quarters · filed 2017-11-07 | $18.35M 10-Q · filed 2017-11-07 | $26.45M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $7.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $14.59M 10-Q · filed 2017-08-08 | $22.68M derived: sum of 3 quarters · filed 2018-02-27 | $27.88M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $7.39M 10-Q · filed 2017-05-09 | $15.48M derived: sum of 2 quarters · filed 2018-02-27 | $20.68M derived: sum of 3 quarters · filed 2018-02-27 | $27.13M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | $8.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | $13.29M derived: sum of 2 quarters · filed 2018-02-27 | $19.74M derived: sum of 3 quarters · filed 2018-02-27 | $26.56M 10-K · filed 2018-02-27 |
| 2015-09-30 | $5.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | $11.65M derived: sum of 2 quarters · filed 2016-11-08 | $18.47M 10-Q · filed 2016-11-08 | $23.28M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $6.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $13.27M 10-Q · filed 2016-08-09 | $18.09M derived: sum of 3 quarters · filed 2017-02-28 | $22.53M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $6.82M 10-Q · filed 2016-05-10 | $11.63M derived: sum of 2 quarters · filed 2017-02-28 | $16.08M derived: sum of 3 quarters · filed 2017-02-28 | $19.86M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $9.26M derived: sum of 2 quarters · filed 2017-02-28 | $13.04M derived: sum of 3 quarters · filed 2017-02-28 | $17.72M 10-K · filed 2017-02-28 |
| 2014-09-30 | $4.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $8.22M derived: sum of 2 quarters · filed 2015-11-09 | $12.91M 10-Q · filed 2015-11-09 | $17.61M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-06-30 | $3.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $8.46M 10-Q · filed 2015-08-05 | $13.16M derived: sum of 3 quarters · filed 2016-02-23 | $16.57M derived: sum of 4 quarters · filed 2016-02-23 |
| 2014-03-31 | $4.69M 10-Q · filed 2015-05-07 | $9.38M derived: sum of 2 quarters · filed 2016-02-23 | $12.80M derived: sum of 3 quarters · filed 2016-02-23 | $16.31M derived: sum of 4 quarters · filed 2016-02-23 |
| 2013-12-31 | $4.70M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $8.11M derived: sum of 2 quarters · filed 2016-02-23 | $11.62M derived: sum of 3 quarters · filed 2016-02-23 | $14.82M 10-K · filed 2016-02-23 |
| 2013-09-30 | $3.42M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | $6.93M derived: sum of 2 quarters · filed 2014-11-04 | $10.13M 10-Q · filed 2014-11-04 | $12.78M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | $3.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | $6.71M 10-Q · filed 2014-08-05 | $9.36M derived: sum of 3 quarters · filed 2015-02-24 | $9.90M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | $3.20M 10-Q · filed 2014-05-08 | $5.85M derived: sum of 2 quarters · filed 2015-02-24 | $6.38M derived: sum of 3 quarters · filed 2015-02-24 | $5.55M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | $2.65M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | $3.19M derived: sum of 2 quarters · filed 2015-02-24 | $2.35M derived: sum of 3 quarters · filed 2015-02-24 | $2.35M 10-K · filed 2015-02-24 |
| 2012-09-30 | $536.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05 | -$300.00K derived: sum of 2 quarters · filed 2013-11-05 | -$301.00K 10-Q · filed 2013-11-05 | -$301.00K derived: sum of 4 quarters · filed 2014-02-25 |
| 2012-06-30 | -$836.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$837.00K 10-Q · filed 2013-08-06 | -$837.00K derived: sum of 3 quarters · filed 2014-02-25 | |
| 2012-03-31 | -$1.00K 10-Q · filed 2013-05-07 | -$1.00K derived: sum of 2 quarters · filed 2014-02-25 | ||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-25 | -$82.00K 10-K · filed 2014-02-25 | ||
| 2011-09-30 | -$82.00K 10-Q · filed 2012-11-09 | |||
| 2010-12-31 | $53.00K 10-K · filed 2013-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |